Lentivirus-mediated Gene Transfer in Hematopoietic Stem Cells Is Impaired in SHIV-infected, ART-treated Nonhuman Primates

Autor: Brian P. Milless, Patricia Polacino, Stephen C. DeRosa, Phil Gafken, John P. Kowalski, Patrick Younan, Willimark M. Obenza, Hannah W. Miller, Shiu Lok Hu, Hans-Peter Kiem, Christopher W. Peterson
Rok vydání: 2015
Předmět:
Transplantation Conditioning
medicine.medical_treatment
Genetic Vectors
Simian Acquired Immunodeficiency Syndrome
Gene Expression
Viremia
Hematopoietic stem cell transplantation
medicine.disease_cause
Immunophenotyping
03 medical and health sciences
0302 clinical medicine
T-Lymphocyte Subsets
Transduction
Genetic

Antiretroviral Therapy
Highly Active

Drug Discovery
medicine
Genetics
Animals
Lymphocyte Count
Transgenes
Molecular Biology
030304 developmental biology
Pharmacology
0303 health sciences
biology
Lentivirus
Hematopoietic Stem Cell Transplantation
virus diseases
Genetic Therapy
Viral Load
Total body irradiation
Simian immunodeficiency virus
Hematopoietic Stem Cells
biology.organism_classification
medicine.disease
Virology
3. Good health
Transplantation
surgical procedures
operative

030220 oncology & carcinogenesis
Immunology
Molecular Medicine
Simian Immunodeficiency Virus
Original Article
Macaca nemestrina
Stem cell
Viral load
Zdroj: Molecular Therapy. 23(5):943-951
ISSN: 1525-0016
DOI: 10.1038/mt.2015.19
Popis: Recent studies have demonstrated that genetically modified hematopoietic stem cells (HSCs) can reduce HIV viremia. We have developed an HIV/AIDS-patient model in Simian/human immunodeficiency virus (SHIV)-infected pigtailed macaques that are stably suppressed on antiretroviral therapy (ART: raltegravir, emtricitabine and tenofovir). Following SHIV infection and ART, animals undergo autologous HSC transplantation (HSCT) with lentivirally transduced cluster of differentiation (CD)34(+) cells expressing the mC46 anti-HIV fusion protein. We show that SHIV(+), ART-treated animals had very low gene marking levels after HSCT. Pretransduction CD34(+) cells contained detectable levels of all three ART drugs, likely contributing to the low gene transfer efficiency. Following HSCT recovery and the cessation of ART, plasma viremia rebounded, indicating that myeloablative total body irradiation cannot completely eliminate viral reservoirs after autologous HSCT. The kinetics of recovery following autologous HSCT in SHIV(+), ART-treated macaques paralleled those observed following transplantation of control animals. However, T-cell subset analyses demonstrated a high percentage of C-C chemokine receptor 5 (CCR5)-expressing CD4(+) T-cells after HSCT. These data suggest that an extended ART interruption time may be required for more efficient lentiviral transduction. To avoid complications associated with ART interruption in the context of high percentages of CD4(+)CCR5(+)T-cells after HSCT, the use of vector systems not impaired by the presence of residual ART may also be beneficial.
Databáze: OpenAIRE